The conviction of John Kapoor and others from Insys Therapeutics represents the first successful prosecution of pharmaceutical executives for crimes related to the opioid crisis, US District Attorney Andrew Lelling said.
The outgoing commissioner requested $55 million to aid the agency's fight against the opioid epidemic.
This eBook provides actionable strategies, real-world best practices to help payers stay ahead in a value-based care environment.
The trial - of Insys founder John Kapoor and four other defendants - had been scheduled to start Monday morning. Two other executives pleaded guilty in November and earlier this month.
Investigative journalism lives in some unlikely places, such as on HBO's "Last Week Tonight with John Oliver." This week, host John Oliver — you know, a comedian by trade — took a deep look at the opioid epidemic in America.
Insys Therapeutics, a Phoenix-based drug development company focused on pain and oncology, will swallow Chicago-area biopharmaceutical developer NeoPharm Inc. (OTC:NEOL.PK) through a reverse merger worth an initial $135 million in stock.